160 related articles for article (PubMed ID: 20467773)
1. Successful treatment of HCV-related cryoglobulinemic glomerulonephritis with double-filtration plasmapheresis and interferon combination therapy.
Namba T; Shiba R; Yamamoto T; Hirai Y; Moriwaki T; Matsuda J; Kadoya H; Takeji M; Yamada Y; Yoshihara H; Yamauchi A
Clin Exp Nephrol; 2010 Aug; 14(4):372-6. PubMed ID: 20467773
[TBL] [Abstract][Full Text] [Related]
2. Rapidly deteriorating renal function with membranoproliferative glomerulonephritis Type 1 associated with hepatitis C treated successfully with steroids and antiviral therapy: a case report and review of literature.
Ahmed MS; Wong CF; Shawki H; Kapoor N; Pandya BK
Clin Nephrol; 2008 Apr; 69(4):298-301. PubMed ID: 18397706
[TBL] [Abstract][Full Text] [Related]
3. Antiviral therapy of symptomatic HCV-mixed cryoglobulinemia after liver transplant: case report and literature review.
Francesca Donato M; Banfi G; Cresseri D; Battista Fogazzi G; Martin P; Messa P; Fabrizi F
Int J Artif Organs; 2013 May; 36(5):367-72. PubMed ID: 23446762
[TBL] [Abstract][Full Text] [Related]
4. Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN.
Alric L; Plaisier E; Thébault S; Péron JM; Rostaing L; Pourrat J; Ronco P; Piette JC; Cacoub P
Am J Kidney Dis; 2004 Apr; 43(4):617-23. PubMed ID: 15042538
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus-related heat-insoluble cryoglobulinemia and thrombotic microangiopathy.
Wu H; Zou HB; Xu Y; Zhang L; Du YJ; Yu JY; Lu RH; Li X
Am J Med Sci; 2013 Oct; 346(4):345-8. PubMed ID: 23744520
[TBL] [Abstract][Full Text] [Related]
6. Complete early virological response was highly achieved by double filtration plasmapheresis plus IFN-beta induction therapy for HCV-1b patients with relapse or no response after previous IFN therapy.
Ishikawa T; Higuchi K; Kubota T; Seki K; Honma T; Yoshida T; Kamimura T; Tasaki K; Hirose S; Suzuki Y
Ther Apher Dial; 2011 Aug; 15(4):400-5. PubMed ID: 21884476
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of double filtration plasmapheresis with pegylated interferon/ribavirin therapy for intractable chronic hepatitis C patients and hepatitis C patients with combined liver cirrhosis by HBV, leading to early viral elimination.
Ohara T; Oteki T; Suzuki T; Suzuki M; Matsuzaki Y
Hepatogastroenterology; 2011; 58(105):133-6. PubMed ID: 21510300
[TBL] [Abstract][Full Text] [Related]
8. Effects of pegylated interferon alpha-2a on hepatitis-C-virus-associated glomerulonephritis.
Sugiura T; Yamada T; Kimpara Y; Fujita N; Goto K; Koyama N
Pediatr Nephrol; 2009 Jan; 24(1):199-202. PubMed ID: 18696119
[TBL] [Abstract][Full Text] [Related]
9. Virological response in patients with hepatitis C virus genotype 1b and a high viral load: impact of peginterferon-alpha-2a plus ribavirin dose reductions and host-related factors.
Yamada G; Iino S; Okuno T; Omata M; Kiyosawa K; Kumada H; Hayashi N; Sakai T
Clin Drug Investig; 2008; 28(1):9-16. PubMed ID: 18081356
[TBL] [Abstract][Full Text] [Related]
10. The effect of combination therapy with interferon and cryofiltration on mesangial proliferative glomerulonephritis originating from mixed cryoglobulinemia in chronic hepatitis C virus infection.
Kiyomoto H; Hitomi H; Hosotani Y; Hashimoto M; Uchida K; Kurokouchi K; Nagai M; Takahashi N; Fukunaga M; Mizushige K; Matsuo H; Yuasa S
Ther Apher; 1999 Nov; 3(4):329-33. PubMed ID: 10608730
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hepatitis C-virus-related glomerulonephritis.
Kamar N; Rostaing L; Alric L
Kidney Int; 2006 Feb; 69(3):436-9. PubMed ID: 16514428
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus-related cryoglobulinemia and glomerulonephritis: pathogenesis and therapeutic strategies.
Garini G; Allegri L; Vaglio A; Buzio C
Ann Ital Med Int; 2005; 20(2):71-80. PubMed ID: 16052839
[TBL] [Abstract][Full Text] [Related]
13. Double-Filtration Plasmapheresis plus Interferon-β for HCV-1b Patients with Non-Sustained Virological Response to Previous Combination Therapy.
Kim SR; Saito J; Imoto S; Komaki T; Nagata Y; Kim KI; Sasase N; Kimura N; Sasatani K; Konishi E; Hasegawa Y; Fujinami A; Ohta M; El-Shamy A; Tanaka Y; Sugano M; Sakashita M; Nakamura A; Tsuchida S; Makino T; Kawada T; Nakajima T; Morikawa T; Muramatsu A; Kasugai H; Hotta H; Kudo M
Digestion; 2011; 84 Suppl 1():10-6. PubMed ID: 22156480
[TBL] [Abstract][Full Text] [Related]
14. [Steroids, interferon-alpha and ribavirin treatment of cryoglobulinemic glomerulonephritis concurrent with HCV infection].
Guarnieri A; Marazzi F; Giorgi MP; Canepari G; Pino C; Moggia E; Manca A; Ghezzi PM
G Ital Nefrol; 2002; 19(1):79-81. PubMed ID: 12165950
[TBL] [Abstract][Full Text] [Related]
15. Interferon-alpha in combination with ribavirin as initial treatment for hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis.
Garini G; Allegri L; Carnevali L; Catellani W; Manganelli P; Buzio C
Am J Kidney Dis; 2001 Dec; 38(6):E35. PubMed ID: 11728995
[TBL] [Abstract][Full Text] [Related]
16. Effects of double-filtration plasmapheresis combined with interferon plus ribavirin for recurrent hepatitis C after living donor liver transplantation.
Takada Y; Ito T; Ueda Y; Haga H; Egawa H; Tanaka K; Uemoto S
Liver Transpl; 2008 Jul; 14(7):1044-7. PubMed ID: 18581485
[TBL] [Abstract][Full Text] [Related]
17. Therapy with interferon-alpha plus ribavirin for membranoproliferative glomerulonephritis induced by hepatitis C virus.
Lopes EP; Valente LM; Silva AE; Kirsztajn GM; Cruz CN; Ferraz ML
Braz J Infect Dis; 2003 Oct; 7(5):353-7. PubMed ID: 14552746
[TBL] [Abstract][Full Text] [Related]
18. Effect of combination therapy (ribavirin and interferon) in HCV-related glomerulopathy.
Sabry AA; Sobh MA; Sheaashaa HA; Kudesia G; Wild G; Fox S; Wagner BE; Irving WL; Grabowska A; El-Nahas AM
Nephrol Dial Transplant; 2002 Nov; 17(11):1924-30. PubMed ID: 12401848
[TBL] [Abstract][Full Text] [Related]
19. Sofosbuvir and Daclatsvir in Treatment of Hepatitis C Virus-related Membranoproliferative Glomerulonephritis With Cryoglobulinemia in a Patient With Hepatitis C Genotype 4.
Elmowafy AY; El Maghrabi HM; Zahab MA; Elwasif SM; Bakr MA
Iran J Kidney Dis; 2018 Nov; 12(6):382-384. PubMed ID: 30595569
[TBL] [Abstract][Full Text] [Related]
20. Modeling hepatitis C virus therapies combining drugs and lectin affinity plasmapheresis.
Tullis RH; Duffin RP; Ichim TE; Joyce JA; Levin NW
Blood Purif; 2010; 29(2):210-5. PubMed ID: 20093829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]